Immunosuppression codes (expiring)
Metadata
- Coding system
- SNOMED CT (UK Clinical Edition)
- Coding system release
- 40.2.0
- Organisation
- NHSD Primary Care Domain Refsets
- Codelist ID
- nhsd-primary-care-domain-refsets/imtemp_cod
- Version Tag
- 20250627
- Version ID
- 0ab0f27d
- Number of codes included
- 110
About
Description
Taken from the `IMTEMP_COD` refset published by NHSD. Contains public sector information licensed under the UK Open Government Licence v3.0 (https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/).
References
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
| code | term |
|---|---|
| 1003473002 | B cell lymphocyte aplasia caused by drug |
| 103077004 | Immunodeficiency secondary to neoplasm |
| 103078009 | Immunodeficiency secondary to trauma |
| 103079001 | Immunodeficiency caused by corticosteroid |
| 103080003 | Immunodeficiency due to radiotherapy |
| 103081004 | Immunodeficiency secondary to chemotherapy |
| 106511000119106 | Long-term current use of mycophenolate |
| 106581000119100 | Long-term current use of cyclosporine |
| 106631000119102 | Long-term current use of infliximab |
| 10746341000119109 | Acquired immune deficiency syndrome complicating childbirth |
| 10838971000119103 | Immunodeficiency caused by long term therapeutic use of drug |
| 113531000119106 | Long term current use of abatacept |
| 113541000119102 | Long-term current use of rituximab |
| 1144907001 | Late acute graft-versus-host disease |
| 1148692008 | Radiation therapy following chemotherapy |
| 1162505005 | Agranulocytosis caused by antithyroid agent |
| 1179409000 | Viral warts due to and following immunosuppressive therapy |
| 118640001 | Radioimmunotherapy |
| 118791000119106 | Aplastic anemia caused by antineoplastic agent |
| 12246211000119101 | Infection due to and following bone marrow transplantation |
| 1234854000 | Dermatosis caused by immunosuppressant |
| 1264007008 | Adenovirus infection in immunocompromised person |
| 1269349006 | Transplantation of stem cell |
| 1279827005 | Neoadjuvant antineoplastic therapy procedure prior to surgery |
| 129771000119107 | Neoplasm following transplantation of bone marrow |
| 133896000 | Care of immunosuppressed patient |
| 140561000119102 | Long-term current use of azathioprine |
| 161669001 | History of bone tissue recipient |
| 16370261000119105 | Disorder due to and following transplantation of stem cell |
| 16623961000119100 | Pancytopenia caused by immunosuppressant |
| 16772161000119102 | Long-term current use of vedolizumab |
| 168520004 | Radiotherapy for immunosuppression |
| 169335009 | External beam radiotherapy with surgery and chemotherapy |
| 169336005 | External beam radiation therapy with chemotherapy |
| 169397004 | Radiochemotherapy by local infiltration |
| 169398009 | Radiochemotherapy: to stop spread |
| 169399001 | Radiochemotherapy via oral route |
| 169400008 | Radiochemotherapy via intravenous route |
| 169402000 | Intraarterial radiochemotherapy |
| 169403005 | Intracavitary radiochemotherapy |
| 174241000112100 | Transplantation of allogeneic hematopoietic stem cell |
| 174251000112102 | History of transplantation of allogeneic hematopoietic stem cell |
| 191008001 | Immunodeficiency following hereditary defective response to Epstein-Barr virus |
| 232417611000119100 | Thrombotic microangiopathy following hemopoietic stem cell transplant |
| 234336002 | Hemopoietic stem cell transplant |
| 234642007 | Age-related immunodeficiency |
| 234643002 | Transient immunodeficiency of infancy |
| 234645009 | Drug-induced immunodeficiency |
| 236854007 | Septic splenitis |
| 23833000 | Poisoning caused by antineoplastic AND/OR immunosuppressive drug |
| 240486003 | Parvoviral aplastic crisis |
| 275828002 | Preventing infection of immunocompromised patient |
| 276628009 | Chloramphenicol-induced neutropenia |
| 278257006 | Peripheral blood stem cell transplantation |
| 290578000 | Antineoplastic poisoning |
| 290773007 | Immunosuppressant poisoning |
| 292196008 | Antineoplastic adverse reaction |
| 292207000 | Melphalan adverse reaction |
| 292255000 | Immunosuppressant adverse reaction |
| 292256004 | Cyclosporin adverse reaction |
| 292257008 | Azathioprine adverse reaction |
| 292699000 | Auranofin adverse reaction |
| 293146004 | Prednisone adverse reaction |
| 293166008 | Dexamethasone adverse reaction |
| 293170000 | Prednisolone adverse reaction |
| 295597003 | Antineoplastic overdose |
| 295799003 | Immunosuppressant overdose |
| 328301000119102 | Pancytopenia due to antineoplastic chemotherapy |
| 328321000119106 | Pancytopenia caused by colchicine |
| 328331000119109 | Pancytopenia caused by non-steroidal anti-inflammatory agent |
| 328371000119107 | Pancytopenia caused by antithyroid drug |
| 328381000119105 | Pancytopenia caused by anticonvulsant |
| 33286000 | Secondary immune deficiency disorder |
| 350691000119103 | Agranulocytosis due to and following administration of antineoplastic agent |
| 367141000000103 | Leflunomide adverse reaction |
| 370388006 | Patient immunocompromised |
| 370391006 | Patient immunosuppressed |
| 38013005 | Immunosuppression |
| 394934009 | Combined preoperative chemotherapy and radiotherapy |
| 394935005 | Combined postoperative chemotherapy and radiotherapy |
| 396780003 | Chemotherapy AND/OR radiation therapy prior to lymphadenectomy |
| 398271008 | Predominantly T-cell defect |
| 402355000 | Acute graft-versus-host disease |
| 402751007 | Dermatosis resulting from immunosuppressive therapy |
| 416702871000119106 | Long-term current use of sarilumab |
| 420614009 | Organic dementia with acquired immunodeficiency syndrome |
| 420774007 | Organic brain syndrome with acquired immunodeficiency syndrome |
| 425229001 | Chemotherapy-induced neutropenia |
| 425843001 | Allogeneic peripheral blood stem cell transplant |
| 425983008 | Autologous peripheral blood stem cell transplant |
| 42852008 | Infectious lymphocytosis |
| 441858005 | Adverse reaction caused by trastuzumab administered by infusion |
| 442108004 | Adverse reaction caused by rituximab administered by infusion |
| 53523003 | Poisoning caused by cactinomycin |
| 61251000119108 | Long-term current use of tacrolimus |
| 61261000119105 | Long-term current use of sirolimus |
| 62479008 | Acquired immune deficiency syndrome |
| 672611000119100 | Long-term current use of telaprevir |
| 698075004 | Syngeneic peripheral blood stem cell transplantation |
| 703423002 | Combined chemotherapy and radiation therapy |
| 709115004 | Transplantation of autologous hematopoietic stem cell |
| 710159007 | Long-term current use of immunosuppressive drug |
| 721239009 | Infection of spleen |
| 721912451000119106 | Long-term current use of risankizumab |
| 736024007 | Pancytopenia caused by medication |
| 767658000 | Neutropenia due to and following chemotherapy |
| 782708002 | Everolimus therapy |
| 782711001 | Secukinumab therapy |
| 866151004 | Lymphocytopenia due to severe acute respiratory syndrome coronavirus 2 |
| 88714009 | Transient hypogammaglobulinemia of infancy |